Skip to main content
Fig. 1 | Renal Replacement Therapy

Fig. 1

From: Roxadustat and transfusional iron overload induced hypothyroidism in a hemodialysis patient: a case report with a literature review

Fig. 1

Tineline of the changes in the thyroid function. The patient took indicated doses of roxadustat three times weekly. After discontinuation of roxadustat, the patient was treated with vadadustat (300 mg daily). Reference ranges of TSH and FT4 were between 0.2 μg and 4.5 µIU/mL and between 0.8 and 1.6 ng/dL, respectively. ND, not detected (< 0.42 ng/dL); TSH, thyroid-stimulating hormone; FT4, free thyroxine

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us